Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22432 | 381 | 24.5 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
320 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY | 39312 |
2978 | 2 | PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY | 2605 |
22432 | 1 | SELF CONTROLLED CASE SERIES//VACCINE SAFETY//IMMUNIZAT SAFETY OFF | 381 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SELF CONTROLLED CASE SERIES | authKW | 1428009 | 7% | 64% | 28 |
2 | VACCINE SAFETY | authKW | 643714 | 14% | 15% | 54 |
3 | IMMUNIZAT SAFETY OFF | address | 519929 | 10% | 18% | 37 |
4 | SELF CONTROLLED CASE SERIES METHOD | authKW | 392704 | 2% | 70% | 7 |
5 | ICES UOTTAWA | address | 262286 | 2% | 55% | 6 |
6 | MINI SENTINEL | authKW | 262286 | 2% | 55% | 6 |
7 | SELF CONTROLLED DESIGNS | authKW | 256461 | 1% | 80% | 4 |
8 | CASE SERIES MODELS | authKW | 240434 | 1% | 100% | 3 |
9 | VACCINE SAFETY DATALINK | authKW | 183184 | 1% | 57% | 4 |
10 | SELF CONTROLLED CASE SERIES DESIGN | authKW | 180324 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Public, Environmental & Occupational Health | 4286 | 43% | 0% | 165 |
2 | Medical Informatics | 1722 | 8% | 0% | 32 |
3 | Statistics & Probability | 1630 | 16% | 0% | 62 |
4 | Mathematical & Computational Biology | 1320 | 11% | 0% | 42 |
5 | Medicine, Research & Experimental | 1225 | 22% | 0% | 83 |
6 | Health Care Sciences & Services | 647 | 9% | 0% | 35 |
7 | Immunology | 546 | 19% | 0% | 74 |
8 | Pharmacology & Pharmacy | 435 | 22% | 0% | 82 |
9 | Pediatrics | 101 | 7% | 0% | 25 |
10 | Infectious Diseases | 77 | 5% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNIZAT SAFETY OFF | 519929 | 10% | 18% | 37 |
2 | ICES UOTTAWA | 262286 | 2% | 55% | 6 |
3 | OFF BIOSTAT EPIDEMIOL | 120659 | 4% | 9% | 16 |
4 | AETNA DATA SCI | 80145 | 0% | 100% | 1 |
5 | AETNA INFORMAT OPERAT TECHNOL | 80145 | 0% | 100% | 1 |
6 | AMBULATORY CARE SERVDENVER HLTH HLTH R | 80145 | 0% | 100% | 1 |
7 | BIOSTAT RECH EPIDEMIOL SANTE POPULAT U1018 | 80145 | 0% | 100% | 1 |
8 | BMIR | 80145 | 0% | 100% | 1 |
9 | CDER OFF BIOSTAT | 80145 | 0% | 100% | 1 |
10 | CDER OFF SURVEILLANCE EPIDEMIOL | 80145 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 101239 | 14% | 2% | 54 |
2 | VACCINE | 13930 | 15% | 0% | 56 |
3 | EPIDEMIOLOGY | 5398 | 3% | 1% | 13 |
4 | STATISTICS IN MEDICINE | 5391 | 6% | 0% | 22 |
5 | JOURNAL OF CLINICAL EPIDEMIOLOGY | 4377 | 4% | 0% | 16 |
6 | AMERICAN JOURNAL OF EPIDEMIOLOGY | 3851 | 6% | 0% | 21 |
7 | CONNECTOR SPECIFIER | 2164 | 0% | 3% | 1 |
8 | SEQUENTIAL ANALYSIS-DESIGN METHODS AND APPLICATIONS | 1882 | 1% | 1% | 2 |
9 | BIOSTATISTICS | 1653 | 1% | 1% | 4 |
10 | BMC MEDICAL RESEARCH METHODOLOGY | 1557 | 1% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEITE, A , ANDREWS, NJ , THOMAS, SL , (2016) NEAR REAL-TIME VACCINE SAFETY SURVEILLANCE USING ELECTRONIC HEALTH RECORDSA SYSTEMATIC REVIEW OF THE APPLICATION OF STATISTICAL METHODS.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 25. ISSUE 3. P. 225 -237 | 28 | 67% | 2 |
2 | GAULT, N , CASTANEDA-SANABRIA, J , DE RYCKE, Y , GUILLO, S , FOULON, S , TUBACH, F , (2017) SELF-CONTROLLED DESIGNS IN PHARMACOEPIDEMIOLOGY INVOLVING ELECTRONIC HEALTHCARE DATABASES: A SYSTEMATIC REVIEW.BMC MEDICAL RESEARCH METHODOLOGY. VOL. 17. ISSUE . P. - | 27 | 77% | 0 |
3 | YIH, WK , KULLDORFF, M , SANDHU, SK , ZICHITTELLA, L , MARO, JC , COLE, DV , JIN, R , KAWAI, AT , BAKER, MA , LIU, CF , ET AL (2016) PROSPECTIVE INFLUENZA VACCINE SAFETY SURVEILLANCE USING FRESH DATA IN THE SENTINEL SYSTEM.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 25. ISSUE 5. P. 481 -492 | 18 | 82% | 3 |
4 | NORDMANN, S , BIARD, L , RAVAUD, P , ESPOSITO-FARESE, M , TUBACH, F , (2012) CASE-ONLY DESIGNS IN PHARMACOEPIDEMIOLOGY: A SYSTEMATIC REVIEW.PLOS ONE. VOL. 7. ISSUE 11. P. - | 21 | 75% | 9 |
5 | WELDESELASSIE, YG , WHITAKER, HJ , FARRINGTON, CP , (2011) USE OF THE SELF-CONTROLLED CASE-SERIES METHOD IN VACCINE SAFETY STUDIES: REVIEW AND RECOMMENDATIONS FOR BEST PRACTICE.EPIDEMIOLOGY AND INFECTION. VOL. 139. ISSUE 12. P. 1805-1817 | 30 | 48% | 31 |
6 | WILSON, K , HAWKEN, S , KWONG, JC , DEEKS, SL , CROWCROFT, NS , MANUEL, D , (2012) VACCINE AND IMMUNIZATION SURVEILLANCE IN ONTARIO (VISION) - USING LINKED HEALTH ADMINISTRATIVE DATABASES TO MONITOR VACCINE SAFETY.VACCINE. VOL. 30. ISSUE 43. P. 6115-6120 | 18 | 75% | 2 |
7 | MARO, JC , BROWN, JS , KULLDORFF, M , (2013) MEDICAL PRODUCT SAFETY SURVEILLANCE HOW MANY DATABASES TO USE?.EPIDEMIOLOGY. VOL. 24. ISSUE 5. P. 692-699 | 20 | 59% | 1 |
8 | LI, RX , STEWART, B , WEINTRAUB, E , (2016) EVALUATING EFFICIENCY AND STATISTICAL POWER OF SELF-CONTROLLED CASE SERIES AND SELF-CONTROLLED RISK INTERVAL DESIGNS IN VACCINE SAFETY.JOURNAL OF BIOPHARMACEUTICAL STATISTICS. VOL. 26. ISSUE 4. P. 686 -693 | 11 | 92% | 0 |
9 | KAWAI, AT , LI, LL , KULLDORFF, M , VELLOZZI, C , WEINTRAUB, E , BAXTER, R , BELONGIA, EA , DALEY, MF , JACOBSEN, SJ , NALEWAY, A , ET AL (2014) ABSENCE OF ASSOCIATIONS BETWEEN INFLUENZA VACCINES AND INCREASED RISKS OF SEIZURES, GUILLAIN-BARRE SYNDROME, ENCEPHALITIS, OR ANAPHYLAXIS IN THE 2012-2013 SEASON.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 23. ISSUE 5. P. 548-553 | 10 | 91% | 9 |
10 | MARO, JC , BROWN, JS , DAL PAN, GJ , KULLDORFF, M , (2014) MINIMIZING SIGNAL DETECTION TIME IN POSTMARKET SEQUENTIAL ANALYSIS: BALANCING POSITIVE PREDICTIVE VALUE AND SENSITIVITY.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 23. ISSUE 8. P. 839 -848 | 19 | 51% | 1 |
Classes with closest relation at Level 1 |